Coromandel International Schedules Board Meeting for Q4FY26 Results and Dividend Consideration
Coromandel International Limited has scheduled a board meeting for May 7, 2026, to approve audited financial results for Q4FY26 covering both standalone and consolidated operations for the quarter and year ended March 31, 2026. The board will also consider declaring final dividend for FY2025-26, subject to approval. The announcement complies with SEBI regulations and has been communicated to NSE and BSE exchanges.

*this image is generated using AI for illustrative purposes only.
Coromandel International Limited has announced that its Board of Directors will convene on May 7, 2026, to review and approve crucial financial matters for the concluded financial year. The company has formally notified both the National Stock Exchange of India and BSE Limited about this important board meeting through a regulatory filing dated May 3, 2026.
Meeting Agenda and Key Decisions
The primary agenda for the board meeting includes consideration and approval of the company's audited financial results for both standalone and consolidated operations. These results will cover the quarter and year ended March 31, 2026, marking the completion of the financial year 2025-26.
| Meeting Details: | Information |
|---|---|
| Date: | May 7, 2026 |
| Primary Agenda: | Audited Financial Results (Q4FY26) |
| Results Type: | Standalone & Consolidated |
| Period Covered: | Quarter and Year ended March 31, 2026 |
Dividend Consideration
The board meeting will also address potential shareholder returns for the financial year 2025-26. The company has indicated that the Board of Directors may consider the payment of final dividend for the concluded financial year during the scheduled meeting. However, any dividend declaration remains subject to board approval and final decision during the meeting.
Regulatory Compliance
The announcement has been made in compliance with Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notification was signed by B. Shanmugasundaram, Company Secretary & Compliance Officer, ensuring proper adherence to regulatory requirements.
| Exchange Details: | Information |
|---|---|
| NSE Symbol: | COROMANDEL |
| BSE Scrip Code: | 506395 |
| Reference Number: | 2026-27/04 |
| Filing Date: | May 3, 2026 |
The company has requested both stock exchanges to take the submission on record, maintaining transparency with investors and regulatory authorities regarding the upcoming board decisions.
Historical Stock Returns for Coromandel International
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.30% | -2.60% | +2.63% | -12.10% | -12.00% | +170.12% |
How might Coromandel's Q4FY26 results impact the fertilizer sector's performance outlook for the upcoming agricultural season?
What dividend yield range could investors expect if the board approves a final dividend, based on the company's historical payout patterns?
Will Coromandel's financial performance influence its expansion plans in the specialty chemicals and crop protection segments?


































